title: Using QALYs in cancer: a review of the methodological limitations.
abstract: The objective of this paper is to examine how well the QALY captures the health gains generated by cancer treatments, with particular focus on the methods for constructing QALYs preferred by the UK National Institute for Health and Clinical Excellence (NICE). Data were obtained using a keyword search of the MEDLINE database and a hand search of articles written by leading researchers in the subject area (with follow up of the references in these articles). Key arguments were discussed and developed at an oncology workshop in September 2009 at the Office of Health Economics. Three key issues emerged. First, the EQ-5D, NICE's preferred measure of health-related quality of life (QOL) in adults, has been found to be relatively insensitive to changes in health status of cancer patients. Second, the time trade-off, NICE's preferred technique for estimating the values of health states, involves making assumptions that are likely to be violated in end-of-life scenarios. Third, the practice of using valuations of members of the general population, as recommended by NICE, is problematic because such individuals typically display a misunderstanding of what it is really like for patients to live with cancer. Because of the way in which it is constructed, the QALY shows important limitations in terms of its ability to accurately capture the value of the health gains deemed important by cancer patients. A research agenda for addressing these limitations is proposed.
authors: Office of Health Economics, London, UK.
authors: Martina
authors: M
authors: Garau
authors: Koonal K
authors: KK
authors: Shah
authors: Anne R
authors: AR
authors: Mason
authors: Qing
authors: Q
authors: Wang
authors: Adrian
authors: A
authors: Towse
authors: Michael F
authors: MF
authors: Drummond
references: Eur J Cancer Care (Engl). 2003 Mar;12(1):20-7
references: 12641553
references: Health Econ. 2007 Apr;16(4):395-405
references: 17006963
references: Eur J Health Econ. 2008 Aug;9(3):237-49
references: 17605057
references: Med Care. 2007 Mar;45(3):259-63
references: 17304084
references: Value Health. 2006 Jul-Aug;9(4):262-71
references: 16903996
references: Eur J Health Econ. 2009 Feb;10(1):15-23
references: 18327677
references: Health Expect. 1999 Dec;2(4):235-244
references: 11281900
references: J Health Econ. 2010 Jul;29(4):536-40
references: 20633775
references: Value Health. 2008 Mar-Apr;11(2):275-84
references: 18380640
references: Health Econ. 2001 Jan;10(1):27-37
references: 11180567
references: J Clin Oncol. 1998 May;16(5):1689-96
references: 9586880
references: Health Technol Assess. 1999;3(9):i-iv, 1-164
references: 10392311
references: Health Qual Life Outcomes. 2009 Jun 24;7:59
references: 19552807
references: Health Policy. 1996 Dec;38(3):189-203
references: 10162421
references: Int J Technol Assess Health Care. 2001 Fall;17(4):488-96
references: 11758293
references: Qual Life Res. 2007 Apr;16(3):509-22
references: 17091359
references: Health Qual Life Outcomes. 2009 Oct 09;7:87
references: 19814834
references: Soc Sci Med. 2002 Dec;55(12):2149-58
references: 12409128
references: Value Health. 2007 Jul-Aug;10(4):266-72
references: 17645681
references: Eur J Cancer Care (Engl). 2004 Dec;13(5):443-53
references: 15606712
references: Med Decis Making. 1995 Apr-Jun;15(2):132-7
references: 7783573
references: J Med Ethics. 1987 Sep;13(3):117-23
references: 3669036
references: Health Econ. 2010 Feb;19(2):125-9
references: 20049843
references: J Clin Epidemiol. 1995 Oct;48(10):1207-14
references: 7561982
references: Ann Med. 2001 Jul;33(5):337-43
references: 11491192
references: J Exp Psychol Gen. 1988 Mar;117(1):3-20
references: 2966229
references: Health Econ. 2009 Mar;18(3):363-72
references: 18702081
references: Med Care. 2007 Sep;45(9):809-11
references: 17712250
references: Qual Life Res. 2003 Sep;12(6):611-9
references: 14516171
references: N Engl J Med. 2010 Feb 4;362(5):460-5
references: 20054039
references: Cancer Invest. 2002;20(7-8):1086-104
references: 12449742
references: Med Decis Making. 1982;2(3):299-309
references: 7169936
references: Health Econ. 2006 Apr;15(4):393-402
references: 16389652
references: Qual Life Res. 2010 May;19(4):489-97
references: 20151207
references: Appl Health Econ Health Policy. 2005;4(4):201-8
references: 16466271
references: J Health Econ. 2003 May;22(3):445-58
references: 12683961
references: Health Econ. 2000 Mar;9(2):109-26
references: 10721013
references: Pharmacoeconomics. 2010;28(4):345-6
references: 20306551
references: Soc Sci Med. 2009 Jan;68(2):362-7
references: 19019518
references: Health Econ. 2009 May;18(5):549-58
references: 18702082
references: Med Care. 2007 Sep;45(9):835-41
references: 17712253
references: Med Decis Making. 1996 Jan-Mar;16(1):36-44
references: 8717597
references: BMJ. 1990 Jun 2;300(6737):1458-60
references: 2379006
references: Health Serv Res. 1972 Summer;7(2):118-33
references: 5044699
references: Pharmacoeconomics. 2005;23(11):1143-53
references: 16277549
references: Qual Life Res. 2003 Sep;12(6):599-607
references: 14516169
references: Med Decis Making. 2008 Jan-Feb;28(1):113-26
references: 17641139
references: Value Health. 2004 Jan-Feb;7(1):70-8
references: 14720132
references: Oncologist. 2007;12 Suppl 1:4-10
references: 17573451
references: Value Health. 2010 Sep-Oct;13(6):853-6
references: 21054659
references: Med Care. 1997 Nov;35(11):1095-108
references: 9366889
references: Med Care. 2007 Sep;45(9):812-9
references: 17712251